Clinical Trial Update: Prevention of Akute Kidney Injury, Hearttransplant, ANP [Phase 3]

View source ↗

Summary

Phase 3 trial update on prevention of acute kidney injury in heart transplant using ANP has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• ANP (atrial natriuretic peptide)

Snippet

Sponsor: Sahlgrenska University Hospital | Conditions: Acute Kidney Injury | Phase 3 | Status: COMPLETED